Abstract
Determination of the expression level of tumor marker PRAME protein is important both for predicting the course of the disease and for monitoring the effectiveness of anticancer therapy. A fluorescently labeled monoclonal antibody to the PRAME protein was obtained by periodate oxidation of glycans followed by modification with a bifunctional azido-oxyamine reagent and a “click” reaction with alkyne-modified sulfonated cyanine dye Cy3. A new approach to the synthesis of a bifunctional azido-oxyamine reagent using the ethoxyethylidene protecting group for oxyamine is proposed. The labeled antibodies were characterized with UV/Vis absorption spectra and the stoichiometry of the modification was determined. It has been demonstrated that the fluorescent antibodies retain affinity and can be used as a diagnostic tool for detecting the residual marker (the PRAME protein) after anticancer therapy.
Similar content being viewed by others
REFERENCES
Wadelin, F., Fulton, J., McEwan, P.A., Spriggs, K.A., Emsley, J., and Heery, D.M., Mol. Cancer, 2010, vol. 9, p. 226. https://doi.org/10.1186/1476-4598-9-226
Al-Khadairi, G. and Decock, J., Cancers, 2019, vol. 11, p. 984. https://doi.org/10.3390/cancers11070984
Wei, R., Dean, D.C., Thanindratarn, P., Hornicek, F.J., Guo, W., and Duan, Z., Cancer Lett., 2020, vol. 479, pp. 54–60. https://doi.org/10.1016/j.canlet.2019.10.024
Xu, Y., Zou, R., Wang, J., Wang, Z., and Zhu, X., Cell Proliferation, 2020, vol. 53, p. E12770. https://doi.org/10.1111/cpr.12770
Epping, M.T., Wang, L., Edel, M.J., Carlee, L., Hernandez, M., and Bernards, R., Cell, 2005, vol. 122, pp. 835–847. https://doi.org/10.1016/j.cell.2005.07.003
Field, M.G., Decatur, C.L., Kurtenbach, S., Gezgin, G., van der Velden, P.A., Jager, M.J., Kozak, K.N., and Harbour, J.W., Clin. Cancer Res., 2016, vol. 22, pp. 1234–1242. https://doi.org/10.1158/1078-0432.CCR-15-2071
Field, M.G., Durante, M.A., Decatur, C.L., Tarlan, B., Oelschlager, K.M., Stone, J.F., Kuznetsov, J., Bowcock, A.M., Kurtenbach, S., and Harbour, J.W., Oncotarget, 2016, vol. 7, pp. 59209–59219. https://doi.org/10.18632/oncotarget.10962
Gerami, P., Yao, Z., Polsky, D., Jansen, B., Busam, K., Ho, J., Martini, M., and Ferris, L.K., J. Am. Acad. Dermatol., 2017, vol. 76, pp. 114–120. https://doi.org/10.1016/j.jaad.2016.07.038
Pankov, D., Sjostrom, L., Kalidindi, T., Lee, S.-G., Sjostrom, K., Gardner, R., McDevitt, M.R., O’Reilly, R., Thorek, D.L.J., Larson, S.M., Veach, D., and Ulmert, D., Oncotarget, 2017, vol. 8, pp. 65917–65931. https://doi.org/10.18632/oncotarget.19579
Ferris, L.K., Gerami, P., Skelsey, M.K., Peck, G., Hren, C., Gorman, C., Frumento, T., and Siegel, D.M., Melanoma Res., 2018, vol. 28, pp. 478–482. https://doi.org/10.1097/CMR.0000000000000478
Wang, W.-L., Gokgoz, N., Samman, B., Andrulis, I.L., Wunder, J.S., and Demicco, E.G., Modern Pathol., 2020. https://doi.org/10.1038/s41379-020-00687-5
Gerber, J.M., Qin, L., Kowalski, J., Smith, B.D., Griffin, C.A., Vala, M.S., Collector, M.I., Perkins, B., Zahurak, M., Matsui, W., Gocke, C.D., Sharkis, S.J., Levitsky, H.I., and Jones, R.J., Am. J. Hematol., 2011, vol. 86, pp. 31–37. https://doi.org/10.1002/ajh.21915
Misyurin, V.A., Finashutina, Y.P., Turba, A.A., Larina, M.V., Solopova, O.N., Lyzhko, N.A., Kesaeva, L.A., Kasatkina, N.N., Aliev, T.K., Misyurin, A.V., and Kirpichnikov, M.P., Dokl. Biochem. Biophys., 2020, vol. 492, pp. 135–138. https://doi.org/10.1134/S1607672920030072
Wolfe, C.A.C. and Hage, D.S., Anal. Biochem., 1995, vol. 231, pp. 123–130. https://doi.org/10.1006/abio.1995.1511
Kölmel, D.K. and Kool, E.T., Chem. Rev., 2017, vol. 117, pp. 10358–10376. https://doi.org/10.1021/acs.chemrev.7b00090
Zuberbühler, K., Casi, G., Bernardes, G.J.L., and Neri, D., Chem. Commun., 2012, vol. 48, pp. 7100–7102. https://doi.org/10.1039/C2CC32412A
Meldal, M. and Tornøe, C.W., Chem. Rev., 2008, vol. 108, pp. 2952–3015. https://doi.org/10.1021/cr0783479
Hudak, J.E., Barfield, R.M., de Hart, G.W., Grob, P., Nogales, E., Bertozzi, C.R., and Rabuka, D., Angew. Chem., Int. Ed. Engl., 2012, vol. 51, pp. 4161–4165. https://doi.org/10.1002/anie.201108130
Kim, C.H., Axup, J.Y., Dubrovska, A., Kazane, S.A., Hutchins, B.A., Wold, E.D., Smider, V.V., and Schultz, P.G., J. Am. Chem. Soc., 2012, vol. 134, pp. 9918–9921. https://doi.org/10.1021/ja303904e
DeForest, C.A. and Tirrell, D.A., Nat. Mater., 2015, vol. 14, pp. 523–531. https://doi.org/10.1038/nmat4219
Khomutov, M.A., Mandal, S., Weisell, J., Saxena, N., Simonian, A.R., Vepsalainen, J., Madhubala, R., and Kochetkov, S.N., Amino Acids, 2010, vol. 38, pp. 509–517. https://doi.org/10.1007/s00726-009-0410-0
Hestand, N.J. and Spano, F.C., Chem. Rev., 2018, vol. 118, pp. 7069–7163. https://doi.org/10.1021/acs.chemrev.7b00581
Barna, G., Reiniger, L., Tátrai, P., Kopper, L., and Matolcsy, A., Hematol. Oncol., 2008, vol. 26, pp. 167–170. https://doi.org/10.1002/hon.855
Uckun, F.M., Jaszcz, W., Ambrus, J.L., Fauci, A.S., Gajl-Peczalska, K., Song, C.W., Wick, M.R., Myers, D.E., Waddick, K., and Ledbetter, J.A., Blood, 1988, vol. 71, pp. 13–29. https://doi.org/10.1182/blood.V71.1.13.13
Powroźnik, B., Kubowicz, P., and Pękala, E., Postepy Hig. Med. Dosw., 2012, vol. 66, pp. 663–673. https://doi.org/10.5604/17322693.1009980
Finashutina, Yu.P., Misyurin, A.V., Akhlynina, T.V., Lyzhko, N.A., Krutov, A.A., Aksenova, E.V., Misyurin, V.A., and Baryshnikov, A.Yu., Russ. J. Biother., 2015, vol. 14, pp. 29–36. https://doi.org/10.17650/1726-9784-2015-14-3-29-36
Chen, Chiao Y.C., Gurudath, Rao K., Hook, J.W., Krugh, T.R., and Sengupta, S.K., Biopolymers, 1979, vol. 18, pp. 1749–1762. https://doi.org/10.1002/bip.1979.360180712
ACKNOWLEDGMENTS
The authors are grateful to the student of the Department of Biology, Moscow State University, E.A. Kokin, for conducting preliminary experiments on modification of model oxidized polyclonal antibodies with an oxyamine reagent (I).
Funding
The development of a method for modifying monoclonal antibodies was supported by the Russian Science Foundation (project 20-15-00361). K.A. Sapozhnikova is grateful for the financial support from the Russian Foundation for Basic Research (project 20-34-90125 “Postgraduates”).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain a description of experiments conducted by any of the authors of this article with the participation of humans or the use of animals as research objects.
CONFLICT OF INTEREST
The authors declare they have no conflicts of interest.
Additional information
Abbreviations: Boc, tert-butyloxycarbonyl; ESI, electrospray ionization; PRAME, preferentially expressed antigen in melanoma; THPTA, tris(3-hydroxypropyltriazolylmethyl)amine.
Rights and permissions
About this article
Cite this article
Sapozhnikova, K.A., Misyurin, A.V., Pestov, N.B. et al. Detection of the PRAME Protein on the Surface of Melanoma Cells Using a Fluorescently Labeled Monoclonal Antibody. Russ J Bioorg Chem 47, 1077–1085 (2021). https://doi.org/10.1134/S1068162021050332
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021050332